161.73

+2.56%↑

93.32

+1.91%↑

BMO

135.42

+2.9%↑

94.74

+3.18%↑

BNS

69.28

+2.87%↑

161.73

+2.56%↑

93.32

+1.91%↑

BMO

135.42

+2.9%↑

94.74

+3.18%↑

BNS

69.28

+2.87%↑

161.73

+2.56%↑

93.32

+1.91%↑

BMO

135.42

+2.9%↑

94.74

+3.18%↑

BNS

69.28

+2.87%↑

161.73

+2.56%↑

93.32

+1.91%↑

BMO

135.42

+2.9%↑

94.74

+3.18%↑

BNS

69.28

+2.87%↑

161.73

+2.56%↑

93.32

+1.91%↑

BMO

135.42

+2.9%↑

94.74

+3.18%↑

BNS

69.28

+2.87%↑

Kodu・Aktsiate loetelu・WisdomTree

WisdomTree

Suletud

SektorRahandus

14.61 4.88

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.89

Max

14.83

Põhinäitajad
By Trading Economics
Sissetulek	20M 40M
Müük	22M 147M
P/E Sektori keskmine	18.56 55.155
Dividenditootlus	0.86
Kasumimarginaal	27.148
Töötajad	360
EBITDA	23M 62M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+29.74% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	0.86% 4.95%
Järgmine tulemuste avaldamine	1. mai 2026
Järgmine dividendimakse kuupäev	27. mai 2026
Järgmine aktsia dividendi kuupäev (ex-date)	13. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-409M 2B
Eelmine avamishind	9.73
Eelmine sulgemishind	14.61

Uudiste sentiment

By Acuity

50%

171 / 441 Pingereas Finance

WisdomTree Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. märts 2026, 23:31 UTC

Kuumad aktsiad

Stocks to Watch: Nike, RH, NCino

31. märts 2026, 22:35 UTC

Tulu

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. apr 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. märts 2026, 23:50 UTC

Omandamised, ülevõtmised, äriostud

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. märts 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. märts 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. märts 2026, 23:21 UTC

Tulu

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. märts 2026, 23:14 UTC

Market Talk

Tulu

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. märts 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss Widens >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. märts 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. märts 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. märts 2026, 21:35 UTC

Tulu

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. märts 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. märts 2026, 21:33 UTC

Tulu

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. märts 2026, 21:32 UTC

Tulu

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. märts 2026, 21:28 UTC

Tulu

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. märts 2026, 21:26 UTC

Tulu

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. märts 2026, 21:25 UTC

Tulu

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. märts 2026, 21:24 UTC

Market Talk

Tulu

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. märts 2026, 21:22 UTC

Tulu

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. märts 2026, 21:22 UTC

Tulu

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. märts 2026, 21:21 UTC

Tulu

Nike's Digital Channel Still Too Promotional, CFO Says

31. märts 2026, 21:20 UTC

Tulu

Nike CEO: Converse Remains Important to Portfolio

Võrdlus sarnastega

Hinnamuutus

WisdomTree Prognoos

Hinnasiht

By TipRanks

29.74% tõus

12 kuu keskmine prognoos

Keskmine 18.06 USD 29.74%

Kõrge 20 USD

Madal 15.5 USD

Põhineb 5 Wall Streeti analüütiku instrumendi WisdomTree 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi WisdomTree aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

171 / 441 Pingereas Rahandus

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Muud aktsiad sektorist

Royal Bank of Canada

161.73

↑ +2.56%

Toronto-Dominion Bank-The

93.32

↑ +1.91%

BMO

Bank Of Montreal

135.42

↑ +2.9%

Canadian Imperial Bank of Commerce

94.74

↑ +3.18%

BNS

Bank of Nova Scotia-The

69.28

↑ +2.87%

WisdomTree

Ülevaade

Aktsiahinna muutus

Põhinäitajad

Soovitused

Dividendid

Turustatistika

Uudiste sentiment

WisdomTree Graafik

Seotud uudised

Võrdlus sarnastega

WisdomTree Prognoos

Hinnasiht

Hinnangu Konsensus

Sentiment

Finantsandmed

Muud aktsiad sektorist